{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:19:10Z","timestamp":1783059550512,"version":"3.54.6"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"\n Objective<\/jats:title>\n \n Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are considered part of a shared disease spectrum. While orbital inflammatory changes have been described in GCA, the presence of increased optic nerve-region metabolic activity in PMR remains unclear. This study aimed to evaluate canalicular optic nerve-region [\n 18<\/jats:sup>\n F]FDG uptake in patients with clinically isolated PMR.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n In this retrospective single-center study, PMR patients (without signs and symptoms of GCA), who underwent [\n 18<\/jats:sup>\n F]FDG PET\/CT were included. [\n 18<\/jats:sup>\n F]FDG uptake in the canalicular optic nerve region was quantified using SUV\n max<\/jats:sub>\n , SUV\n mean<\/jats:sub>\n and target-to-background ratios (TBR). Patients with unremarkable [\n 18<\/jats:sup>\n F]FDG PET\/CT served as controls, and patients with GCA were included for comparison.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n PMR patients (\n n<\/jats:italic>\n \u00a0=\u00a018) showed significantly higher optic nerve-region [\n 18<\/jats:sup>\n F]FDG uptake compared to controls (median TBR 5.5 [IQR 2.8 \u2013 8.9] vs 2.2 [1.9 \u2013 2.7],\n p<\/jats:italic>\n \u00a0=\u00a00.0006). Patients without immunosuppressive therapy demonstrated higher uptake than treated patients. Notably, untreated PMR patients showed canalicular optic nerve-region uptake values comparable to those observed in active GCA (7.3 [5.9 \u2013 9.8] vs 8.0 [5.2 \u2013 10.0],\n p<\/jats:italic>\n \u00a0=\u00a00.9799). No PMR patient reported visual symptoms.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n \n Patients with clinically isolated PMR showed increased [\n 18<\/jats:sup>\n F]FDG uptake in the canalicular optic nerve region compared with controls, particularly in the absence of immunosuppressive therapy. Uptake values in untreated PMR overlapped with those observed in active GCA. These exploratory findings are compatible with subclinical inflammatory involvement within the GCA-PMR spectrum, but subclinical cranial GCA and non-neural sources of FDG uptake cannot be excluded. Larger prospective studies are required.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1869837","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:39:19Z","timestamp":1783057159000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased optic nerve-region [18F]FDG uptake in clinically isolated polymyalgia rheumatica: an exploratory PET\/CT study within the GCA-PMR spectrum"],"prefix":"10.3389","volume":"17","author":[{"given":"Sebastian E.","family":"Serfling","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Rheumatology and Clinical Immunology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Zhi","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick-Pascal","family":"Strunz","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Rheumatology and Clinical Immunology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Labinsky","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Rheumatology and Clinical Immunology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Hartrampf","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten A.","family":"Bley","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstanze V.","family":"Guggenberger","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Neuroradiology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"Werner","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Ludwig-Maximilians-Universit\u00e4t (LMU) University Hospital, Ludwig-Maximilians-Universit\u00e4t (LMU) Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gernert","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Rheumatology and Clinical Immunology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103415","article-title":"Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases","volume":"23","author":"Salvarani","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae043","article-title":"Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica","volume":"64","author":"Seitz","year":"2025","journal-title":"Rheumatol (Oxford)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf169","article-title":"Vascular MRI also depicts musculoskeletal manifestations in giant-cell arteritis-polymyalgia rheumatica spectrum disease patients","volume":"64","author":"Kern","year":"2025","journal-title":"Rheumatol (Oxford)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae208","article-title":"Prevalence, characteristics, and outcome of subclinical vasculitis in polymyalgia rheumatica: a retrospective cohort study","volume":"63","author":"Moreel","year":"2024","journal-title":"Rheumatol (Oxford)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152017","article-title":"Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data","volume":"55","author":"Hemmig","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152069","article-title":"Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - A systematic review and meta-analysis","volume":"56","author":"Nielsen","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01436-9","article-title":"Large-vessel vasculitis","volume":"406","author":"Cacoub","year":"2025","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-09256-7","article-title":"Intraorbital findings in giant cell arteritis on black blood MRI","volume":"33","author":"Guggenberger","year":"2023","journal-title":"Eur Radiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1802935","article-title":"18F]-FDG-PET\/CT detects subclinical optic nerve inflammation in giant cell arteritis","volume":"17","author":"Gernert","year":"2026","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep011","article-title":"Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI","volume":"48","author":"Geiger","year":"2009","journal-title":"Rheumatol (Oxford)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.155218","article-title":"American College of radiology and society of nuclear medicine and molecular imaging joint credentialing statement for PET\/MR imaging: brain","volume":"56","author":"Jadvar","year":"2015","journal-title":"J Nucl Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2024-326608","article-title":"Optic nerve sheath enhancement on orbital MRI in giant cell arteritis","volume":"109","author":"Ephrem","year":"2025","journal-title":"Br J Ophthalmol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869837\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:39:20Z","timestamp":1783057160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869837\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":13,"alternative-id":["10.3389\/fimmu.2026.1869837"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1869837","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"article-number":"1869837"}}